Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
, 7 (10), 5272-5280

BMI Trajectories and Risk of Overall and Grade-Specific Prostate Cancer: An Observational Cohort Study Among Men Seen for Prostatic Conditions

Observational Study

BMI Trajectories and Risk of Overall and Grade-Specific Prostate Cancer: An Observational Cohort Study Among Men Seen for Prostatic Conditions

Kai Wang et al. Cancer Med.


Background: Dynamic longitudinal patterns in body mass index (BMI) have been suggested to better predict health outcomes than static measures. Effects of BMI trajectories on prostate cancer (PCa) risk have not been thoroughly explored.

Methods: Cohort data were derived from electronic medical records of patients who were admitted to a tertiary-care hospital in the Southeastern USA during 1994-2016. Patients with a history of urologic clinic visit because of any prostatic condition and with repeatedly measured BMI (n = 4857) were included. BMI trajectories prior to PCa diagnosis were assessed using the developmental trajectory analysis method. Cox proportional hazards regression modeling was used to estimate adjusted hazard ratio (aHR) with 95% confidence intervals (CIs) for overall and grade-specific PCa.

Results: The median age (interquartile range, IQR) of the participants at baseline was 63 (54, 72) years. Over a median follow-up (IQR) of 8.0 (2.0, 13.0) years, 714 (14.7%, 714/4857) were diagnosed with PCa. Men with growing BMI trajectory progressing from normal weight to overweight/obese had a 76% increased PCa risk (aHR = 1.76; 95% CI: 1.25, 2.48), and men being obese and experiencing progressive weight gain had 3.72-fold increased PCa risk (aHR = 3.72; 95% CI: 1.60, 8.66), compared to men with persistently normal BMI. The associations were more pronounced for PCa with Gleason score ≥7. No significant association of decreasing BMI trajectory progressing from obese to normal BMI was found with PCa risk.

Conclusions: Progressively body weight gain during middle-to-late adulthood was associated with increased PCa risk for both normal weight and overweight men. Further studies are warranted to confirm this finding.

Keywords: Gleason score; body mass index (BMI); developmental trajectory analysis; middle-to-late adulthood; prostate cancer.


Figure 1
Figure 1
Longitudinal BMI trajectories of men with height and weight measured in clinical settings up to date of prostate cancer diagnosis. Participants were patients seen for prostatic conditions at a tertiary‐care hospital located in Southeastern USA, 1994‐2016

Similar articles

See all similar articles

Cited by 3 PubMed Central articles


    1. Flegal KM, Kruszon‐Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284‐2291. - PubMed
    1. Hanyuda A, Ogino S, Qian ZR, et al. Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate. Int J Cancer. 2016;139:854‐868. - PMC - PubMed
    1. Cadeau C, Fournier A, Mesrine S, Clavel‐Chapelon F, Fagherazzi G, Boutron‐Ruault MC. Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: evidence from the E3N cohort. Int J Cancer. 2016;139:2193‐2200. - PubMed
    1. Rota M, Rumi F, Bagnardi V, et al. Modelling body mass index and endometrial cancer risk in a pooled‐analysis of three case‐control studies. BJOG. 2016;123:285‐292. - PubMed
    1. Lee SE, Hong SK, Park HZ, et al. Higher body mass index is associated with lower risk of prostate cancer detection via multi (≥ 12)‐core prostate biopsy in Korean men. Urology. 2010;76:1063‐1066. - PubMed

Publication types